FIELD: medicine.
SUBSTANCE: invention concerns experimental medicine, namely experimental oncology and can be used for creating a malignant tumour growing in a pulmonary tissue. Therefore, for 14-21th day following transplantation of sarcomas C-45 in outbread male albino rats, a tumour of one animal is removed with a sterile appliance; connective tissue capsule is separated, a piece of a viable greyish-pink tumour tissue is selected and transferred to a sterile Petri dish. Then it is washed with a physiologic saline and transferred in a sterile homogeniser; the tumour is crushed. The prepared tumour pulp is dissolved in sterile physiologic saline in the volume ratio 1:5 and filled in a sterile syringe. The outbread male albino rats are fixed laying on back to introduce the tumour slurry into the subclavian vein in a dose 0.5 ml with observing the aseptic procedure.
EFFECT: method provides 100 % reproducibility, ensuring engrafting of tumour transplants in all cases, and also possibility of mass experiments for relatively short time and in a greater amount with simplicity of implementation.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MAKING TUMOR DISEASE PROPHYLAXIS UNDER EXPERIMENTAL CONDITIONS | 2004 |
|
RU2268070C2 |
METHOD OF MODIFYING THE DEVELOPMENT OF ADENOCARCINOMA EXPERIMENTALLY | 2020 |
|
RU2743960C1 |
METHOD FOR SIMULATION OF EXPERIMENTAL MALIGNANT TUMOURS OF LUNGS | 2008 |
|
RU2375758C1 |
METHOD FOR CREATING ORTHOTOPIC ENDOMETRIAL CANCER MODEL | 2024 |
|
RU2818464C1 |
METHOD FOR PREVENTION OF PULMONARY METASTATIC LESIONS EXPERIMENTALLY | 2013 |
|
RU2546034C1 |
METHOD OF STIMULATING CHRONIC PAIN OF MALIGNANT GROWTH IN LUNG RATS | 2018 |
|
RU2676641C1 |
METHOD FOR SIMULATING LIVER METASTASES EXPERIMENTALLY | 2013 |
|
RU2538243C1 |
METHOD FOR CREATING POLYNEOPLASIA WITH STIMULATION OF TUMOR GROWTH IN CONDITIONS OF PRIMARY IMMUNODEFICIENCY IN EXPERIMENT | 2021 |
|
RU2751930C1 |
METHOD OF TREATING LUNG CANCER IN EXPERIMENT | 2009 |
|
RU2405595C2 |
METHOD FOR ENHANCING THE GROWTH OF B16/F10 MELANOMA VERSUS THE GROWTH OF B16/F10 MELANOMA WITH SELF-GRAFTING AND SLOWING THE GROWTH OF LLC (LEWIS CARCINOMA) VERSUS THE GROWTH OF LLC WITH SELF-GRAFTING IN CASE OF MULTIPLE PRIMARY MALIGNANT TUMORS AGAINST THE BACKGROUND OF PRIMARY IMMUNODEFICIENCY | 2021 |
|
RU2759487C1 |
Authors
Dates
2010-04-27—Published
2008-08-11—Filed